亚洲心力衰竭护理的当前和未来
Sang Gune K Yoo1, Mohammed O Ahmed1, Nancy K Sweitzer1
1Cardiovascular Division, Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO, USA.
International journal of heart failure
|November 8, 2024
概括
由于人口老龄化和非传染性疾病,亚洲心力衰竭 (HF) 正在增加. 这篇评论探讨了亚洲HF治疗,临床试验差距,以及未来的策略,如多药和增强的提供者培训.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 心力衰竭 (HF) 是一个日益严重的全球健康挑战,不成比例地影响亚洲.
- 该地区因人口变化和非传染性疾病的增加而面临越来越多的HF负担.
- 现有的HF治疗方法在亚洲人群中使用率不同.
研究的目的:
- 为亚洲目前心力衰竭的现状提供全面的概述.
- 在亚洲背景下确定高频管理的关键挑战和差异.
- 探索创新策略和未来方向,以改善亚洲的HF护理.
主要方法:
- 这项研究采用了叙事审查方法.
- 文献搜索侧重于心力衰竭流行病学,治疗,临床试验和亚洲的实施.
- 分析综合了关于区域差异,研究差距和治疗进展的发现.
主要成果:
- 在亚洲国家,HF治疗利用率存在显著差异.
- 亚洲人群在全球主要的HF疗法临床试验中仍然不足.
- 新兴的疗法和实施策略,包括多种药物,显示出改善HF结果的希望.
结论:
- 解决亚洲日益增加的心力衰竭负担需要量身定制的战略.
- 在临床试验中增加亚洲人的代表性对于基于证据的实践至关重要.
- 加强医疗保健提供者培训和创新的交付模式,如多种药物,对于未来的高温管理至关重要.
相关概念视频
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Rheumatic Heart Disease III: Medical Management
3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
391
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
391
Imbalances in Cardiac Output
1.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
Rheumatic Heart Disease IV: Nursing Management
5
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
5
Heart Failure Drugs: Inotropic Agents
523
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
523


